Inflammatix has partnered with the University of Nebraska Medical Center and the National Quarantine Unit to deploy its TriVerity® test for rapid assessment of hantavirus infections. The test analyzes the body's immune response via host mRNA to determine bacterial or viral infection likelihood and risk of severe illness within 7 days, delivering results in about 30 minutes. This approach helps clinicians quickly identify patients at risk of deterioration, improving treatment decisions, patient triage, and resource allocation during outbreaks. The collaboration highlights a shift from traditional pathogen detection to immune response-based diagnostics in managing high-risk infectious diseases.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Experian PLC started its 2027 financial year with a 10% revenue increase in the first quarter, driven by strong demand in North America and Latin America. Organic growth was 7%, with North America growing 7% despite a 2% drop in consumer services due...
Gooch & Housego, a UK-listed photonics company specializing in precision optics for aerospace and defence, has agreed to a £345.6 million takeover by US private equity firm Arlington Capital Partners. The offer values the company at a 41.3% premium t...
Aave DAO has proposed an innovative mobile app that integrates fiat currency deposits, self-custody, and decentralized finance (DeFi) lending in one platform. This app allows users to convert fiat to stablecoins and earn yields without needing extern...
Analysts expect Netflix to report $12.6 billion in revenue for Q2 and $51.3 billion for the full year 2026. The operating margin forecast has been revised down from 33% to 32% due to anticipated higher expenses, with an expected operating profit of $...
